This content is machine translated Subtyping as the key to precision medicine Molecular diversity of the PDAC Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive tumors of all. The five-year survival rate is still in the single digits. In recent years, however, there has been...…
View Post 12 min This content is machine translated HER2-positive breast cancer ENPP1 as a biomarker for poor prognosis and early detection of brain metastases Around 15-20% of all breast cancer cases are HER2-positive, which is a subtype with an aggressive course and an increased tendency to metastasize to the brain. A new study now...…
View Post 9 min This content is machine translated Myelofibrosis New treatment options for myelofibrosis patients with a high risk of anemia? Myelofibrosis is considered one of the most complex myeloproliferative neoplasms – with high symptom burden, progressive cytopenia and limited treatment options – with anemia in particular presenting a clinical challenge...…
View Post 6 min This content is machine translated Actinic keratosis Field-directed therapy methods: what the European guideline recommends Topically applied medications are a cornerstone of the field-directed treatment of actinic keratoses. In photodynamic therapy, a topical agent is combined with a procedural method. In cases of insufficient response,...…
View Post 6 min This content is machine translated Colorectal cancer Is exercise better than medication? The presentation by a renowned Canadian oncologist on promising treatment options for colorectal cancer through exercise therapy caused quite a stir at this year’s ASCO. The results of a randomized...…
View Post 12 min This content is machine translated Multiple myeloma DREAMM-8: Key study in the development of BCMA therapy up to DREAMM-14 The DREAMM-8 data presented at this year’s ASCO provided robust evidence of the efficacy and tolerability of the BPd combination (belantamab mafodotin, pomalidomide and dexamethasone) for the treatment of recurrent...…
View Post 13 min This content is machine translated Focus on prevention Colorectal cancer screening – an update Colorectal cancer is a relevant disease for society: every twentieth person in Switzerland is affected at least once in their lifetime. In Switzerland, around 4300 new cases occur every year...… CME-Test
View Post 3 min This content is machine translated Prostate cancer Diagnosis without drama – ESMO 2025 under the banner of differentiated patient management The annual ESMO Congress of the European Society for Medical Oncology, which was held this year in Berlin from October 17 to 21, 2025, offered an impressive variety of topics...…
View Post 16 min This content is machine translated Low-grade pediatric gliomas Consideration of the tumor microenvironment opens up new treatment options Low-grade gliomas are among the most common primary brain tumors in childhood and can affect patients for life, which is why early diagnosis involving the tumor microenvironment is of significant...… CME-Test
View Post 3 min This content is machine translated From symptom to diagnosis Oncology – Thymoma Thymomas are tumors of the thymus and are benign in around 75% of cases. A quarter of thymomas are malignant – they are divided into malignant thymomas and thymic carcinomas...…
View Post 6 min This content is machine translated Case report, molecular basis and therapeutic implications HER2-positive colorectal carcinoma with invasive micropapillary component Colorectal cancer (CRC) is one of the most common and deadliest forms of cancer worldwide. Molecular subgroups are increasingly relevant for prognosis and therapy. In addition to established markers such...…
